An audit to assess the impact of new directives about the use of aprotinin on re-exploration rates and blood product usage after adult cardiac surgery.
Shariq Ali
SA
Khan
Mohan
M
Jayarajah
Bennett
B
Ahlijah
D000328:Adult; D007611:Aprotinin / Q000008:administration & dosage*; D016913:Blood Component Transfusion / Q000706:statistics & numerical data* / Q000639:trends; D006348:Cardiac Surgical Procedures / Q000009:adverse effects* / Q000639:trends; D006801:Humans; D008485:Medical Audit / Q000379:methods* / Q000639:trends; D019106:Postoperative Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D012086:Reoperation / Q000706:statistics & numerical data* / Q000639:trends
D007611:Aprotinin